Clinical Value of Persistent but Downgraded Vesicoureteral Reflux after Dextranomer/Hyaluronic Acid Injection in Children.
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3346/jkms.2013.28.7.1060
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Minki BAEK
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Min Young KANG
			        		
			        		;
		        		
		        		
		        		
			        		Hahn Ey LEE
			        		
			        		;
		        		
		        		
		        		
			        		Kwanjin PARK
			        		
			        		;
		        		
		        		
		        		
			        		Hwang CHOI
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Vesico-Ureteral Reflux;
			        		
			        		
			        		
				        		Endoscopy;
			        		
			        		
			        		
				        		Pyelonephritis;
			        		
			        		
			        		
				        		Pediatrics
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Antibiotic Prophylaxis;
				        		
			        		
				        		
					        		Child;
				        		
			        		
				        		
					        		Child, Preschool;
				        		
			        		
				        		
					        		Dextrans/*therapeutic use;
				        		
			        		
				        		
					        		Female;
				        		
			        		
				        		
					        		Fever/complications/epidemiology;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Hyaluronic Acid/*therapeutic use;
				        		
			        		
				        		
					        		Incidence;
				        		
			        		
				        		
					        		Male;
				        		
			        		
				        		
					        		Retrospective Studies;
				        		
			        		
				        		
					        		Treatment Outcome;
				        		
			        		
				        		
					        		Urinary Tract Infections/complications/drug therapy/*epidemiology;
				        		
			        		
				        		
					        		Vesico-Ureteral Reflux/*drug therapy/surgery
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Journal of Korean Medical Science
	            		
	            		 2013;28(7):1060-1064
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:English
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	We aimed to investigate the clinical value of persistent but downgraded vesicoureteral reflux (VUR) after dextranomer/hyaluronic acid (Dx/HA) injection in children. The medical records of 128 children (195 ureters) who underwent Dx/HA injections for VUR were reviewed. The incidences of pre- and post-operative febrile urinary tract infections (UTIs) were analyzed in children with or without persistent VUR on voiding cystourethrography (VCUG) 3 months postoperatively. The surgical results of VUR persistent children who underwent a single additional injection were assessed. The VUR resolved completely in 100 ureters (51.3%), was persistent in 95 ureters, and newly developed in 2 ureters. The incidence of pre/post-operative febrile UTIs were 0.35 +/- 0.39 per year and 0.07 +/- 0.32 per year in VUR resolved children (P < 0.001), and 0.76 +/- 1.18 per year and 0.20 +/- 0.61 per year in VUR persistent children (P < 0.001). A single additional Dx/HA injection (44 ureters) resolved VUR in 29 ureters (65.9%), and also reduced the VUR to grade I in 7 ureters (15.9%), II in 4 (9.1%), and III in 4 (9.1%). Even in children with persistent VUR after Dx/HA injection, the incidence of febrile UTIs decreased markedly. The VUR grade significantly decreases after single additional Dx/HA injection.